Publications
124
Citations
5,827
Est. group size
—
Recurring co-author estimate
Active years
43
Publishing since 1983
This researcher studies neurofibromatosis type 2 (NF2), a genetic condition that causes tumors such as schwannomas and meningiomas to grow on nerves, particularly around hearing and balance nerves. The work focuses on understanding the molecular biology of these tumors, especially the loss of a tumor-suppressor protein called merlin, and testing drug combinations (such as c-Met, Src, and MEK inhibitors) that might slow or stop tumor growth. Some publications also touch on related areas like malignant peripheral nerve sheath tumors (MPNSTs) and pediatric sarcoma treatment.
Publication output has fluctuated over the past decade, with a notable spike in 2023 followed by a return to more modest yearly counts, averaging about 5 publications per year over the last 5 years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Increased Hemorrhage During Excision of Bevacizumab‐Treated <scp>NF2</scp> ‐Related Vestibular Schwannomas
The Laryngoscope · 2025
- Impact of Consolidative Radiation on Overall and Progression Free Survival in Pediatric, Adolescent and Young Adult Metastatic Sarcoma
International Journal of Radiation Oncology*Biology*Physics · 2023
- Figures S1-S4 and Supplementary Methods from Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
2023
- Data from Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
2023
- Figures S1-S4 and Supplementary Methods from Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
2023
- Data from Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
2023
- Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy
Science Advances · 2022
- The technology for detection of gamma-ray burst with GECAM satellite
Radiation Detection Technology and Methods · 2021
- Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2–associated schwannomas reveals differences in efficacy and drug resistance development
Neuro-Oncology · 2019
- Brigatinib and Its Combination with INK-128 as a Novel Treatment for NF2-Deficient Meningiomas
2019
- Whether pericarcinomatous tissue of non-small cell lung cancer can serve as genetic background filter in next-generation sequencing analysis
Annals of Oncology · 2018
- Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells
Oncotarget · 2017
- Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells
Molecular Cancer Therapeutics · 2017
- The NUP98 Gene as a Potential Modifier of NF2-Associated Tumors
2017
- Generation of Noninvasive, Quantifiable, Orthotopic Animal Models for NF2-Associated Schwannoma and Meningioma
Methods in molecular biology · 2016
- Neuro-Oncology×5
- PLoS ONE×2
- Science Advances×2
- Molecular Cancer Therapeutics×2
- Radiation Detection Technology and Methods×1
- Janet L. Oblinger
Medicine · The Ohio State University
- Eric Hawley
Medicine · Indiana University
- Abbi E. Smith
Medicine · Indiana University
- D. Wade Clapp
Medicine · Indiana University
- Chi Zhang
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile